Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5208112
Max Phase: Preclinical
Molecular Formula: C24H34O2
Molecular Weight: 354.53
Associated Items:
ID: ALA5208112
Max Phase: Preclinical
Molecular Formula: C24H34O2
Molecular Weight: 354.53
Associated Items:
Canonical SMILES: C=CCOc1ccc2c(c1)C[C@@H]1[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]1(C)O2
Standard InChI: InChI=1S/C24H34O2/c1-6-14-25-18-8-9-19-17(15-18)16-21-23(4)12-7-11-22(2,3)20(23)10-13-24(21,5)26-19/h6,8-9,15,20-21H,1,7,10-14,16H2,2-5H3/t20-,21+,23-,24+/m0/s1
Standard InChI Key: AGENWNRBIWJBGS-SGKWCMOWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 354.53 | Molecular Weight (Monoisotopic): 354.2559 | AlogP: 6.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 18.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.33 | CX LogD: 6.33 |
Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.60 | Np Likeness Score: 1.94 |
1. Wang X, Hu N, Kong W, Song B, Li S.. (2022) Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads., 227 [PMID:34653771] [10.1016/j.ejmech.2021.113912] |
Source(1):